Nightingale Health Oyj (FRA:7XE)

Market Cap	57.95M -59.2%
Revenue (ttm)	5.50M +17.2%
Net Income	-18.47M
EPS	-0.30
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55
Open	0.7920
Previous Close	0.7600
Day's Range	0.7920 - 0.7920
52-Week Range	0.6720 - 2.5600
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 16, 2026

About Nightingale Health Oyj

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare...

• Industry: Medical Laboratories
• Founded: 2002
• Employees: 101
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7XE

Financial Performance

In fiscal year 2026, Nightingale Health Oyj's revenue was 5.50 million, an increase of 17.24% compared to the previous year's 4.69 million. Losses were -18.47 million, 0.06% more than in 2025.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 25, 2026

Data Sources Report a data error